25 of the Best Oncologists Near Me in Fairfax, VA

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Alexander Spira is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Spira is highly rated in 96 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Leslie Randall is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Randall is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hysterectomy.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Christina Annunziata is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Annunziata is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Testicular Yolk Sac Tumor.

George Maxwell is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Falls Church, Virginia. Dr. Maxwell is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Uterine Fibroids, Hysterectomy, and Intrauterine Device Insertion.

Dipti Patel is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Patel is highly rated in 79 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Timothy Mccarthy is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Mccarthy is highly rated in 78 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Daniel Chong is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Chong is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Robert Reid is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Reid is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Danielle Shafer is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Shafer is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Myringotomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

"Dr. Timothy Cannon is Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova. He is a specialty care physician board certified in medical oncology. He has a special interest in management of gastrointestinal malignancies.Dr. Cannon is the clinical director and moderator of the weekly molecular tumor board at Inova, which matches patients with targeted therapies based on molecular diagnostics. He is very interested in national cooperative group clinical trials and is a member of the NRG colorectal and non-colorectal clinical trials committee. He is the site principal investigator for multiple clinical trials in immunotherapy.Dr. Cannon is chair-elect of the steering committee for the TAPUR trial, which is the largest oncology basket trial in North America. He also served as the chief fellow of hematology/oncology at New York University (NYU). Dr. Cannon was voted fellow of the year at NYU during each of his last two years there. He received a ""best doctor"" award by Northern Virginia magazine in 2015.A native of New Jersey, Dr. Cannon is married with two sons. His wife, Amy, works for Save the Children. In his spare time, he likes to play sports (particularly soccer, flag football, tennis) and read books. He was a member of two Division I basketball teams (University of Utah as a freshman and then later at Brigham Young University) in the 1990s and continues to be a huge basketball fan.". Dr. Cannon is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Amin Benyounes is a board-certified medical oncologist specializing in thoracic cancers and early-phase clinical trials. Before joining Inova, Dr. Benyounes served as an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore. He currently serves as the Director of Phase I/Developmental Therapeutics at Inova Schar Cancer and is the Deputy Director of the Molecular Tumor Board. Dr. Benyounes is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Pleuropulmonary Blastoma.

Dr. Raymond Wadlow is a specialty care physician board certified in medical oncology and internal medicine. He has a special interest in gastrointestinal oncology. Dr. Wadlow joined Inova Health System in 2020 and has been practicing since 2006. A native of Charlottesville, VA, Dr. Wadlow resides in Fairfax, VA, with his wife and three children. Outside of work, he enjoys cycling, traveling and visiting museums. Dr. Wadlow is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, and Pancreaticoduodenectomy.

Dr. Marion Cole is a specialty care physician board certified in hematology and medical oncology. She joined Inova in 2016 and has been practicing since 2013. Prior to joining Inova, Dr. Marion Cole worked as an oncologist in Fairfax, VA. Dr. Cole has a special interest in hematologic malignancies, multiple myeloma, lymphoma and myelodysplastic syndromes (MDS). She believes that all patients deserve comprehensive care for physical, emotional and spiritual needs when being treated for cancer. Outside of work, Dr. Cole enjoys reading mysteries, hiking, traveling and spending time with family. Dr. Cole is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Breast Cancer, Polycythemia Vera, and Paget Disease of the Breast.

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Dr. Angel Yu is a specialty oncology care physician board certified in medical oncology, hematology and internal medicine at Inova Health System. She joined Inova in 2020 and has been in medical practice since 2012. Her area of interest is genitourinary cancers, which include prostate, bladder, kidney, and testicular cancers. She completed her undergraduate education at the University of Pennsylvania with a major in biology, after which she received her doctorate in medicine at the Drexel University College of Medicine. She completed her internal medicine and hematology/oncology training at The George Washington University in Washington, D.C. Prior to joining Inova, Dr. Yu worked as a medical oncologist and hematologist with Novant Health and CaroMont Health, both based in North Carolina. She is excited to return to the D.C. area to focus on providing compassionate, personalized and evidence-based oncology care to patients with genitourinary cancers. Dr. Yu is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Prostate Cancer, and Non-Small Cell Lung Cancer (NSCLC).

Gregory Orloff is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Orloff is highly rated in 67 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Paget Disease of the Breast, and Familial Pancreatic Cancer.

Brownstein Chair, Brain Tumor Research Co-Director, Neuro-Oncology, Inova Schar CancerDr. Adam L. Cohen is a specialty care physician board certified in neuro-oncology, medical oncology and internal medicine. He received his MS from the University of Chicago and MD from Harvard. Dr. Cohen is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Glioblastoma, Neuroepithelioma, Bone Marrow Aspiration, and Liver Embolization.

John Elkas is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Elkas is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Oophorectomy, and Hernia Surgery.

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy. Dr. Sahebjam is board certified in American Board Of Internal Medicine.

Gaylord Rose is an Oncologist and an Obstetrics and Gynecologist practicing medicine in Fairfax, Virginia. Dr. Rose is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Bladder Reconstruction.

William Ershler is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Ershler is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Congenital Hemolytic Anemia, and Hemolytic Anemia.